Your browser doesn't support javascript.
loading
Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study.
Boyer, Michael; Sendur, Mehmet A N; Rodríguez-Abreu, Delvys; Park, Keunchil; Lee, Dae Ho; Çiçin, Irfan; Yumuk, Perran Fulden; Orlandi, Francisco J; Leal, Ticiana A; Molinier, Olivier; Soparattanapaisarn, Nopadol; Langleben, Adrian; Califano, Raffaele; Medgyasszay, Balazs; Hsia, Te-Chun; Otterson, Gregory A; Xu, Lu; Piperdi, Bilal; Samkari, Ayman; Reck, Martin.
Affiliation
  • Boyer M; Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
  • Sendur MAN; Ankara Yildirim Beyazit University, Faculty of Medicine and Ankara City Hospital, Ankara, Turkey.
  • Rodríguez-Abreu D; Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Lee DH; Asan Medical Center, Seoul, South Korea.
  • Çiçin I; Trakya University, Erdine, Turkey.
  • Yumuk PF; Marmara University School of Medicine, Istanbul, Turkey.
  • Orlandi FJ; Orlandi-Oncología, Providencia, Chile.
  • Leal TA; University of Wisconsin Carbone Cancer Center, Madison, WI.
  • Molinier O; Hospital of Le Mans, Le Mans, France.
  • Soparattanapaisarn N; Mahidol University, Sriraj Hospital, Bangkok, Thailand.
  • Langleben A; St Mary's Hospital - ODIM, McGill University Department of Oncology, Montreal, QC, Canada.
  • Califano R; The Christie NHS Foundation Trust, and Division of Cancer Sciences, The University of Manchester, Manchester, UK.
  • Medgyasszay B; Veszprém Megyei Tüdogyógyintézet Farkasgyepu, Farkasgyepu, Hungary.
  • Hsia TC; China Medical University and China Medical University Hospital, Taichung, Taiwan.
  • Otterson GA; The Ohio State University-James Comprehensive Cancer Center, Columbus, OH.
  • Xu L; Merck & Co, Inc, Kenilworth, NJ.
  • Piperdi B; Merck & Co, Inc, Kenilworth, NJ.
  • Samkari A; Merck & Co, Inc, Kenilworth, NJ.
  • Reck M; LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
J Clin Oncol ; 39(21): 2327-2338, 2021 07 20.
Article in En | MEDLINE | ID: mdl-33513313
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Antibodies, Monoclonal, Humanized / B7-H1 Antigen / Ipilimumab / Lung Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: Australia Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Antibodies, Monoclonal, Humanized / B7-H1 Antigen / Ipilimumab / Lung Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: Australia Country of publication: United States